In a randomized, double-blind, placebo-controlled clinical trial with 44 patients of NAFLD, ginger supplementation significantly reduced the levels of ALT, inflammatory cytokines, γ-glutamyl transferase, as well as hepatic steatosis grade and the insulin resistance index in comparison to the control group. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.